RPSA
ABBV icon

Richard P. Slaughter Associates’s AbbVie ABBV Stock Holding History

Richard P. Slaughter Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756K Sell
3,006
-962
-24% -$207K 0.15% 60
2026
Q1 		$863K Sell
3,968
-337
-8% -$74.8K 0.19% 53
2025
Q4 		$984K Sell
4,305
-201
-4% -$45.8K 0.21% 54
2025
Q3 		$1.04M Sell
4,506
-590
-12% -$120K 0.22% 53
2025
Q2 		$946K Sell
5,096
-5
-0.1% -$929 0.19% 64
2025
Q1 		$1.07M Buy
+5,101
New +$992K 0.25% 58
2022
Q1 		– Sell
-22,714
Closed -$3.08M – 130
2021
Q4 		$3.08M Buy
22,714
+416
+2% +$49.1K 1.09% 26
2021
Q3 		$2.4M Sell
22,298
-1,491
-6% -$170K 0.95% 30
2021
Q2 		$2.68M Buy
23,789
+310
+1% +$34.9K 1.04% 29
2021
Q1 		$2.54M Sell
23,479
-3,710
-14% -$397K 1.05% 28
2020
Q4 		$2.91M Buy
27,189
+140
+0.5% +$13.5K 1.23% 25
2020
Q3 		$2.37M Buy
27,049
+1,152
+4% +$108K 1.09% 26
2020
Q2 		$2.54M Sell
25,897
-5,177
-17% -$456K 1.11% 25
2020
Q1 		$2.37M Buy
31,074
+2,054
+7% +$175K 1.24% 19
2019
Q4 		$2.57M Buy
+29,020
New +$2.41M 1.02% 37

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Richard P. Slaughter Associates's ABBV Position: Q2 2026 in Review

Richard P. Slaughter Associates reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $207K and leaving 3,006 shares worth $756K. The position accounts for 0.15% of the portfolio, ranked #60.

Richard P. Slaughter Associates first reported a position in ABBV in Q4 2019 and has held it in 15 quarters since. The position peaked at $3.08M in Q4 2021. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Richard P. Slaughter Associates held 3,006 shares of AbbVie worth $756K as of Q2 2026.
  • Richard P. Slaughter Associates sold 962 AbbVie shares in Q2 2026, an estimated $207K.
  • AbbVie made up 0.15% of Richard P. Slaughter Associates's portfolio in Q2 2026, its #60 holding.
  • Richard P. Slaughter Associates first reported a position in AbbVie in Q4 2019 and has held it in 15 quarters since.
  • Richard P. Slaughter Associates's AbbVie position peaked at $3.08M in Q4 2021.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Richard P. Slaughter Associates's 13F filing for Q2 2026, filed 13 Jul 2026.